Centripetal distribution of body fat, overweight and cardiorespiratory fitness: Association with insulin sensitivity and metabolic alterations;Distribuição centrípeta da gordura corporal, sobrepeso e aptidão cardiorrespiratória: Associação com sensibilidade insulínica e alterações metabólicas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 6, 2006, Pages 1034-1040

  Da Silva, José Luciano T ^a   Barbosa, Décio Sabbatini ^b   De Oliveira, Jair Aparecido ^b   Guedes, Dartagnan Pinto ^b,c  

^a UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c Condomínio Royal Golf ^*  (Brazil)

Author keywords

Blood pressure; Centripetal obesity; Insulin resistance; Metabolic syndrome

Indexed keywords

LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR FUNCTION; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY FUNCTION; RISK FACTOR; SEX DIFFERENCE; WAIST HIP RATIO;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BODY MASS INDEX; CARDIOVASCULAR PHYSIOLOGY; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; OXYGEN CONSUMPTION; PHYSICAL FITNESS; RESPIRATORY PHYSIOLOGY; RISK FACTORS; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WAIST-HIP RATIO;

EID: 33846396420     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000600009     Document Type: Article

References (31)

1. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Paaarikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle intervention among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
2. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003;26:3230-6.
3. Park HS, Lee K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 2005;22:266-72.
4. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005;288:E454-61.
5. Després JP. Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipid 1991;2:5-15.
6. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001;49:119-26.
7. You T, Yang R, Lyles MF, Gong D, Nicklas BJ. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 2005;288:E741-7.
8. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
10. Lohman TG. Anthropometric Standardization Reference Manual. Champaign: Human Kinetics, 1988.
11. 2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc 1987;19:253-9.
12. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH, et al. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 2004;12:1805-13.
13. Carr DB, Utzasghneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-94.
14. Karter AJ, D'Agostino RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab 2005;7:230-8.
15. Hoefle G, Saely CH, Aczel S, Benzer W, Marte T, Langer P, et al. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes Relat Metab Disord 2005;29:785-91.
16. Janssen I, Katzmarzyk PT, Ross R, Leon AS, Skinner JS, Rao DC, et al. Fitness alters the associations of BMI and waist circumference with total and abdominal fat. Obes Res 2004;12:525-37.
17. Feldstain CA, Akopian M, Olivieri AO, Kramer AP, Garrido D. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: A hospital-based study. Nutr Metab Cardiovasc Dis 2005;15:310-5.
18. Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord 2002;26:48-57.
19. Karlssom C, Lindell K, Ottosson M, Sjöström L, Carlsson B, Carlsson LMS. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998;83:3925-9.
20. Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003;5:386-92.
21. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating alfa 2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alfa. Implications for the female fat distribution. J Clin Endocrinol Metab 2004;89:1869-78.
22. Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 2002;106:2526-9.
23. Lönnqvist F, Thorne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 1997;17:1472-80.
24. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-32.
25. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S, et al. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-7.
26. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003;149:331-5.
27. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003;11:997-1001.
28. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:746-9.
29. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-53.
30. Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005;7:406-13.
31. Stewart KJ, Bacher AC, Turner K, Lim JG, Hees PS, Shapiro EP, et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am J Prev Med 2005;28:9-18.